Investigation of X Financial

X Financial (XYF) Accused of Misleading Investors in IPO

According to the complaint for alleged violations of the Securities Act of 1933 pursuant to its September 2018 initial public offering ("IPO"), X Financial completed its IPO on September 19, 2018, offering 11.7 million American Depositary Shares ("ADSs") at $9.50 per ADS and raising more than $111 million in gross proceeds. Leading up to the IPO, X Financial claimed the Company was growing rapidly. Despite positive forward-looking statements, in November 2018, the Company's financial results for third quarter 2018 revealed a 40% sequential increase and 270% year-over-year increase in the delinquency rate for X Financial loans and a significant reduction in loans facilitated in the quarter. Then on April 25, 2019, X Financial disclosed in its annual report for 2018 on Form 20-F that there had been a dramatic increase in delinquency rates leading up to and during the IPO and that these negative trends were accelerating. Finally, on May 21, 2019, X Financial revealed in an earnings call that the Company was unlikely to achieve significant loan or revenue growth because its referred loan business had failed. Since these disclosures, X Financial's ADSs have consistently traded below $9.50. The stock currently trades at around $1.80 per ADS, representing an 80% plummet from its IPO price.

Send us a message for more information.

Additional Alerts for Shareholders

Pharmaceutist reaching for medications on pharmacy shelves

uniQure N.V. Class Action Lawsuit

Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Leading Drug Candidate, AMT-130 Robbins LLP informs stockholders

Read More »
Free!
Skip to content